FACULTY AFFILIATIONS

	Dianne D Chapman, ND, RN, ANP Nurse Practitioner, Comprehensive Breast Center/RISC Program Division of Hematology and Oncology Rush University Medical Center Chicago, Illinois		Harold J Burstein, MD, PhD Assistant Professor of Medicine Harvard Medical School Breast Oncology Center Dana-Farber Cancer Institute Boston, Massachusetts
	Hope S Rugo, MD Clinical Professor of Medicine Carol Franc Buck Breast Care Center Co-director, Breast Oncology Clinical Trials Program University of California, San Francisco Comprehensive Cancer Center San Francisco, California		Stephen E Jones, MD Director, Breast Cancer Research Charles A Sammons Cancer Center Baylor University Medical Center Dallas, Texas Chair, US Oncology Breast Cancer Research Medical Director US Oncology Research Houston, Texas
	Mark D Pegram, MD Associate Professor of Medicine David Geffen School of Medicine at UCLA Director, Women’s Cancer Program UCLA/Jonsson Comprehensive Cancer Center Los Angeles, California

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CNE activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and external, independent reviewers for fair balance, scientific objectivity of studies referenced and patient care recommendations.

The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process: Lisa Aiello-Laws, RN, MSN, APN,C, AOCNS, John H Brebner, Regina Seery Cunningham, PhD, RN, AOCN, Richard Kaderman, PhD, Neil Love, MD, Paula Mateo, RN, BA, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech BioOncology. Research To Practice receives education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Genentech BioOncology/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr Chapman — Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Genomic Health Inc, Genentech BioOncology. Dr Rugo — Contracted Research: Genentech BioOncology. Dr Pegram — Consulting Fees: Genentech BioOncology, Sanofi-Aventis; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Genentech BioOncology, Sanofi-Aventis. Dr Burstein — Speakers Bureau: Amgen Inc, Genentech BioOncology. Dr Jones — Consulting Fees: Genentech BioOncology, Sanofi-Aventis; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Sanofi-Aventis.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

 

Table of Contents

Top of Page